$12.84 2.5%
EMBC Stock Price vs. AI Score (Last 150 days)
Data gathered: July 16

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Embecta

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes.

Price $12.84
Target Price Sign up
Volume 347,410
Market Cap $760M
Year Range $10.02 - $18.91
Dividend Yield 4.56%
PE Ratio 10.8
Revenue per Employee $512,227
Industry Medical Devices

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '24287M194M185M29M82M0.670
Q4 '23276M184M186M20M51M0.610
Q3 '23278M208M182M6M44M0.590
Q2 '23286M184M190M15M55M0.260
Q1 '23277M173M190M14M59M0.240

Insider Transactions View All

Melcher David F filed to buy 27,698 shares at $15.8.
September 8 '23
Elguicze Jacob filed to buy 66,027 shares at $21.7.
August 10 '23
Mann Jeffrey Z filed to buy 55,333 shares at $21.7.
August 10 '23
Kurdikar Devdatt filed to buy 244,791 shares at $21.8.
August 10 '23
Melcher David F filed to buy 21,465 shares at $32.5.
February 15 '23

What is the Market Cap of Embecta?

The Market Cap of Embecta is $760M.

What is Embecta's PE Ratio?

As of today, Embecta's PE (Price to Earnings) ratio is 10.8.

How Many People Work at Embecta?

As of our latest update, Embecta employed approximately 2,200 people worldwide. However, it's important to note that Embecta's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Embecta's revenue per employee?

$512,227. To calculate Embecta's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Embecta?

Currently, the price of one share of Embecta stock is $12.84.

How can I analyze the EMBC stock price chart for investment decisions?

The EMBC stock price chart above provides a comprehensive visual representation of Embecta's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Embecta shares. Our platform offers an up-to-date EMBC stock price chart, along with technical data analysis and alternative data insights.

Does EMBC offer dividends to its shareholders?

Yes, Embecta (EMBC) offers dividends to its shareholders, with a dividend yield of 4.56%. This dividend yield represents Embecta's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Embecta in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of Embecta?

Some of the similar stocks of Embecta are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.